Developer docs
API playgroundTry for free, no card

Search company profiles

Drumetix

Full company profile

uuid0024h9y

Namestring
Drumetix
Legal namestring
Drumetix Laboratories, LLC
Websiteurl
drumetix.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Drumetix Laboratories, LLC is a pharmaceutical contract research organization (CRO) headquartered in Greensboro, North Carolina, providing in vitro and in vivo DMPK, bioanalytical, and protein characterization services to pharmaceutical, biotechnology, and academic clients. Its core offering spans ADME assays (permeability, plasma stability, protein binding, metabolic stability, CYP inhibition, glutathione conjugation), small molecule biomarker analysis (neurotransmitters, atRA, creatinine, desmosine), metabolite identification, GLP and non-GLP bioanalysis, analytical method development, stability testing, and biotherapeutic protein characterization including ADC DAR determination. The laboratory operates Sciex triple quadrupole mass spectrometers for quantitative LC-MS/MS work and a Bruker maXis II QTof with high resolution, high mass accuracy, and electron transfer dissociation (ETD) for advanced protein and metabolite characterization.

The business operates on a fee-for-service, project-based contract research model. Pricing is not publicly disclosed and is expected to vary by study design, sample count, assay type, and regulatory tier (GLP vs non-GLP). Go-to-market is direct B2B sales to pharmaceutical and biotech companies and academic institutions; in vivo PK studies are delivered through partner cooperation rather than in-house vivarium capability, allowing the lab to focus capital on mass spectrometry infrastructure. Distribution is global in scope but executed from a single US site. The company is privately held with no disclosed institutional funding or parent entity.

Drumetix competes on scientific depth in drug metabolism and mass spectrometry, instrument capability breadth (notably ETD-enabled protein work), and dual-track GLP/non-GLP turnaround flexibility. Its service menu has expanded from small-molecule DMPK into biotherapeutics characterization and environmental cyanotoxin analysis, suggesting deliberate platform broadening within an otherwise niche CRO footprint.

Short descriptiontext

Drumetix Laboratories is a pharmaceutical contract research organization (CRO) providing in vitro and in vivo DMPK, bioanalytical, and protein characterization services on LC-MS/MS platforms to pharmaceutical, biotech, academic, and environmental clients from its Greensboro, NC laboratory.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGreensboro, United States
HQ citystring
Greensboro
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical CRO services, drug metabolism pharmacokinetics, bioanalytical LC-MS/MS, ADME assay services, protein characterization CRO
Industry4 codes
PRIMARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAHAF
Small-Molecule Analytical Development & Method Validation (CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Research Services (DMPK/Bioanalytical CRO)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Fee-for-service contract research organization providing DMPK, bioanalytical, and protein characterization services to pharmaceutical companies and academic institutions. Revenue generated through project-based contracts for drug metabolism studies, bioanalysis, stability testing, and other analytical services.

drumetix.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Drumetix Laboratories is a pharmaceutical contract research organization that provides in vitro and in vivo DMPK (drug metabolism and pharmacokinetics) services, bioanalytical support, small molecule biomarker analysis, stability testing, and LC/MS-based protein characterization for drug discovery and preclinical/clinical development. Services are delivered from its Greensboro, North Carolina laboratory using LC-MS/MS instrumentation including Sciex triple quadrupole and Bruker maXis II QTof platforms, supporting both rapid-turnaround non-GLP discovery studies and GLP-compliant regulatory work.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Quick turnaround DMPK assays and non-GLP bioanalysis for PK screening and candidate selection
+2 more records
Product overview1 text field

Drumetix Laboratories is a pharmaceutical contract research organization (CRO) providing comprehensive drug metabolism and pharmacokinetics (DMPK) and bioanalytical services. The company offers an integrated portfolio of services organized around core capabilities: In Vitro DMPK (ADME) assays including permeability, plasma stability, protein binding, metabolic stability, CYP inhibition, and glutathione conjugation testing; Small Molecule Biomarkers analysis using LC-MS/MS for neurotransmitters, retinoids, and creatinine; Bioanalytical Services encompassing metabolite identification, non-GLP and GLP bioanalysis, and method development and validation; Analytical Services for API characterization and impurity analysis; Stability Testing for drug substances and products; and Biological Services for protein characterization, biotherapeutics bioanalysis, and protein biomarker quantification. The laboratory is equipped with Sciex triple quadrupole instruments and a Bruker maXis II QTof instrument with high resolution, high mass accuracy, and electron transfer dissociation (ETD) capabilities. Services are provided for both discovery and preclinical/clinical development stages.

Product and service1 record
1In Vitro DMPK (ADME) Services
Partnership1 partner
1In Vivo PK Study Partners
Strategic tierCoreTypeOthers
Description

Drumetix provides in vivo PK studies (in-life) through cooperation with partners. This partnership enables the laboratory to offer comprehensive DMPK services including in vivo studies alongside their in vitro capabilities and bioanalytical services.

drumetix.com
Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Celerion is a clinical pharmacology and early-phase CRO offering bioanalytical, ADME, and DMPK services to pharma and biotech. It is highly comparable to Drumetix in service mix (LC-MS/MS bioanalysis, ADME assays, biomarker analysis) and target customers, though it operates at a larger scale.

2Pyxant Labs
TypeDirect peer
Description

Pyxant Labs (formerly PBI International) is a bioanalytical CRO specializing in LC-MS/MS small-molecule and biomarker analysis for pharmaceutical and academic clients. Directly comparable to Drumetix in boutique bioanalytical CRO positioning and scientific service scope.

TypeBroad incumbent
Description

Eurofins is a global testing group with a sizable bioanalytical and pharmaceutical services footprint, including DMPK, ADME, and biomarker capabilities. It competes broadly with Drumetix for outsourced bioanalytical work and has acquired specialty DMPK firms (e.g., Absorption Systems).

TypeDirect peer
Description

BASi is a CRO providing bioanalytical, DMPK, and drug discovery services including LC-MS/MS sample analysis and contract research. Directly comparable to Drumetix as a small/mid-size specialty bioanalytical CRO serving pharma and academic customers.

TypeDirect peer
Description

Frontage Laboratories provides bioanalytical, CMC, and DMPK services to pharma and biotech, including LC-MS/MS method development and validation. Comparable in service scope (GLP bioanalysis, DMPK, biomarkers), though Frontage operates at significantly larger scale.

6Absorption Systems
TypeDirect peer
Description

Absorption Systems (now part of Eurofins) is a specialty CRO focused on ADME/DMPK, permeability, and pharmacokinetic studies using in vitro and in vivo models. Directly comparable to Drumetix's core in vitro DMPK and PAMPA-style permeability offerings for pharmaceutical discovery programs.

TypeDirect peer
Description

Sekisui Xenotech provides in vitro ADME services including metabolic stability, CYP reaction phenotyping, and protein binding using hepatic models. Closely comparable to Drumetix's metabolic stability, CYP inhibition, and protein binding assay portfolio serving pharma DMPK programs.

TypeBroad incumbent
Description

Charles River is a global CRO with extensive DMPK, safety assessment, and bioanalytical services. It is a broad incumbent competing with Drumetix for pharma DMPK outsourcing at much larger scale and global footprint.

TypeBroad incumbent
Description

Labcorp Drug Development is a leading global CRO offering bioanalytical, ADME, and clinical pharmacology services. A broad incumbent directly competing with Drumetix for outsourced LC-MS/MS bioanalysis and DMPK projects.

TypeBroad incumbent
Description

WuXi AppTec is a large global CRO/CDMO providing DMPK, bioanalytical, and drug discovery services. A broad incumbent that competes with Drumetix for outsourced DMPK and bioanalysis, particularly from biopharma sponsors.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Drumetix

Pharmaceutical Contract Research Services (DMPK/Bioanalytical CRO)drumetix.com

Drumetix Laboratories is a pharmaceutical contract research organization (CRO) providing in vitro and in vivo DMPK, bioanalytical, and protein characterization services on LC-MS/MS platforms to pharmaceutical, biotech, academic, and environmental clients from its Greensboro, NC laboratory.

What Drumetix does

Drumetix Laboratories, LLC is a pharmaceutical contract research organization (CRO) headquartered in Greensboro, North Carolina, providing in vitro and in vivo DMPK, bioanalytical, and protein characterization services to pharmaceutical, biotechnology, and academic clients. Its core offering spans ADME assays (permeability, plasma stability, protein binding, metabolic stability, CYP inhibition, glutathione conjugation), small molecule biomarker analysis (neurotransmitters, atRA, creatinine, desmosine), metabolite identification, GLP and non-GLP bioanalysis, analytical method development, stability testing, and biotherapeutic protein characterization including ADC DAR determination. The laboratory operates Sciex triple quadrupole mass spectrometers for quantitative LC-MS/MS work and a Bruker maXis II QTof with high resolution, high mass accuracy, and electron transfer dissociation (ETD) for advanced protein and metabolite characterization.

The business operates on a fee-for-service, project-based contract research model. Pricing is not publicly disclosed and is expected to vary by study design, sample count, assay type, and regulatory tier (GLP vs non-GLP). Go-to-market is direct B2B sales to pharmaceutical and biotech companies and academic institutions; in vivo PK studies are delivered through partner cooperation rather than in-house vivarium capability, allowing the lab to focus capital on mass spectrometry infrastructure. Distribution is global in scope but executed from a single US site. The company is privately held with no disclosed institutional funding or parent entity.

Drumetix competes on scientific depth in drug metabolism and mass spectrometry, instrument capability breadth (notably ETD-enabled protein work), and dual-track GLP/non-GLP turnaround flexibility. Its service menu has expanded from small-molecule DMPK into biotherapeutics characterization and environmental cyanotoxin analysis, suggesting deliberate platform broadening within an otherwise niche CRO footprint.

Drumetix firmographics

Firmographics
Name
Drumetix
Legal name
Drumetix Laboratories, LLC
Website
https://drumetix.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1–10 employees
Short description
Drumetix Laboratories is a pharmaceutical contract research organization (CRO) providing in vitro and in vivo DMPK, bioanalytical, and protein characterization services on LC-MS/MS platforms to pharmaceutical, biotech, academic, and environmental clients from its Greensboro, NC laboratory.
Ownership category
akta.pro rank

Drumetix industry classification

Industry
Product category
Pharmaceutical Contract Research Services (DMPK/Bioanalytical CRO)
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAFAC
DMPK / ADME & Bioanalysis
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAHAF
Small-Molecule Analytical Development & Method Validation (CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGANAG
Metabolomics & Lipidomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • Pharmaceutical CRO services
  • Drug metabolism pharmacokinetics
  • Bioanalytical LC-MS/MS
  • ADME assay services
  • Protein characterization CRO

Where Drumetix is headquartered

Location

Headquarters

HQ city
Greensboro
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Drumetix business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Research Services: Fee-for-service contract research organization providing DMPK, bioanalytical, and protein characterization services to pharmaceutical companies and academic institutions. Revenue generated through project-based contracts for drug metabolism studies, bioanalysis, stability testing, and other analytical services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Drumetix product offering

Product offering

Core offering

Drumetix Laboratories is a pharmaceutical contract research organization that provides in vitro and in vivo DMPK (drug metabolism and pharmacokinetics) services, bioanalytical support, small molecule biomarker analysis, stability testing, and LC/MS-based protein characterization for drug discovery and preclinical/clinical development. Services are delivered from its Greensboro, North Carolina laboratory using LC-MS/MS instrumentation including Sciex triple quadrupole and Bruker maXis II QTof platforms, supporting both rapid-turnaround non-GLP discovery studies and GLP-compliant regulatory work.

Product overview

Drumetix Laboratories is a pharmaceutical contract research organization (CRO) providing comprehensive drug metabolism and pharmacokinetics (DMPK) and bioanalytical services. The company offers an integrated portfolio of services organized around core capabilities: In Vitro DMPK (ADME) assays including permeability, plasma stability, protein binding, metabolic stability, CYP inhibition, and glutathione conjugation testing; Small Molecule Biomarkers analysis using LC-MS/MS for neurotransmitters, retinoids, and creatinine; Bioanalytical Services encompassing metabolite identification, non-GLP and GLP bioanalysis, and method development and validation; Analytical Services for API characterization and impurity analysis; Stability Testing for drug substances and products; and Biological Services for protein characterization, biotherapeutics bioanalysis, and protein biomarker quantification. The laboratory is equipped with Sciex triple quadrupole instruments and a Bruker maXis II QTof instrument with high resolution, high mass accuracy, and electron transfer dissociation (ETD) capabilities. Services are provided for both discovery and preclinical/clinical development stages.

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vitro DMPK (ADME) Services

Quantifiable outcome

  • Quick turnaround DMPK assays and non-GLP bioanalysis for PK screening and candidate selection
  • +2 more outcomes

Companies that use Drumetix

Customer profile

Segments3 records

Ideal customer profiles3 records

Drumetix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Drumetix partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • In Vivo PK Study PartnerscoreOthersDrumetix provides in vivo PK studies (in-life) through cooperation with partners. This partnership enables the laboratory to offer comprehensive DMPK services including in vivo studies alongside their in vitro capabilities and bioanalytical services.

Expansion highlights3 records

Drumetix competitors and assessment

Company assessment

Direct peers

  • Celerion: Celerion is a clinical pharmacology and early-phase CRO offering bioanalytical, ADME, and DMPK services to pharma and biotech. It is highly comparable to Drumetix in service mix (LC-MS/MS bioanalysis, ADME assays, biomarker analysis) and target customers, though it operates at a larger scale.
  • Pyxant Labs: Pyxant Labs (formerly PBI International) is a bioanalytical CRO specializing in LC-MS/MS small-molecule and biomarker analysis for pharmaceutical and academic clients. Directly comparable to Drumetix in boutique bioanalytical CRO positioning and scientific service scope.
  • Bioanalytical Systems, Inc. (BASi): BASi is a CRO providing bioanalytical, DMPK, and drug discovery services including LC-MS/MS sample analysis and contract research. Directly comparable to Drumetix as a small/mid-size specialty bioanalytical CRO serving pharma and academic customers.
  • Frontage Laboratories: Frontage Laboratories provides bioanalytical, CMC, and DMPK services to pharma and biotech, including LC-MS/MS method development and validation. Comparable in service scope (GLP bioanalysis, DMPK, biomarkers), though Frontage operates at significantly larger scale.
  • Absorption Systems: Absorption Systems (now part of Eurofins) is a specialty CRO focused on ADME/DMPK, permeability, and pharmacokinetic studies using in vitro and in vivo models. Directly comparable to Drumetix's core in vitro DMPK and PAMPA-style permeability offerings for pharmaceutical discovery programs.
  • Sekisui Xenotech (formerly XenoTech): Sekisui Xenotech provides in vitro ADME services including metabolic stability, CYP reaction phenotyping, and protein binding using hepatic models. Closely comparable to Drumetix's metabolic stability, CYP inhibition, and protein binding assay portfolio serving pharma DMPK programs.

Broad incumbents

  • Eurofins Scientific: Eurofins is a global testing group with a sizable bioanalytical and pharmaceutical services footprint, including DMPK, ADME, and biomarker capabilities. It competes broadly with Drumetix for outsourced bioanalytical work and has acquired specialty DMPK firms (e.g., Absorption Systems).
  • Charles River Laboratories: Charles River is a global CRO with extensive DMPK, safety assessment, and bioanalytical services. It is a broad incumbent competing with Drumetix for pharma DMPK outsourcing at much larger scale and global footprint.
  • Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a leading global CRO offering bioanalytical, ADME, and clinical pharmacology services. A broad incumbent directly competing with Drumetix for outsourced LC-MS/MS bioanalysis and DMPK projects.
  • WuXi AppTec: WuXi AppTec is a large global CRO/CDMO providing DMPK, bioanalytical, and drug discovery services. A broad incumbent that competes with Drumetix for outsourced DMPK and bioanalysis, particularly from biopharma sponsors.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Drumetix social profiles

Digital presence

Drumetix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Drumetix leadership team

Management profile

Number of profiles

Drumetix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Drumetix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Drumetix

What does Drumetix do?

Drumetix Laboratories is a pharmaceutical contract research organization that provides in vitro and in vivo DMPK (drug metabolism and pharmacokinetics) services, bioanalytical support, small molecule biomarker analysis, stability testing, and LC/MS-based protein characterization for drug discovery and preclinical/clinical development. Services are delivered from its Greensboro, North Carolina laboratory using LC-MS/MS instrumentation including Sciex triple quadrupole and Bruker maXis II QTof platforms, supporting both rapid-turnaround non-GLP discovery studies and GLP-compliant regulatory work.

Is Drumetix a public or private company?

Drumetix is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Drumetix founded?

Drumetix was founded in 2000. It employs 1 to 10 people.

Where is Drumetix based?

Drumetix is headquartered in Greensboro, United States, in the North America region.

How does Drumetix make money?

One revenue line is on record: contract Research Services.

Who are Drumetix's main competitors?

Direct peers on record are Celerion, Pyxant Labs, Bioanalytical Systems, Inc. (BASi), Frontage Laboratories, Absorption Systems and Sekisui Xenotech (formerly XenoTech). Broad incumbents are Eurofins Scientific, Charles River Laboratories, Labcorp Drug Development (formerly Covance) and WuXi AppTec.

Does Drumetix have an API?

No public API is recorded for Drumetix.

What industry is Drumetix in?

Drumetix's product category is Pharmaceutical Contract Research Services (DMPK/Bioanalytical CRO). Its primary akta.pro industry code is HLAGAFAC, DMPK / ADME & Bioanalysis, with a secondary code of HLAGAEAG, Bioanalytical & PK/PD Sample Analysis (Trial Support). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales